| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| COX1 |
P00395
|
cytochrome c oxidase subunit I
|
Enzyme
|
|
0.441 |
0.885 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| PDR |
|
pigment disorder, reticulate
|
|
|
0.592 |
0.692 |
| ERVW-1 |
Q9UQF0
|
endogenous retrovirus group W member 1, envelope
|
|
|
0.505 |
0.692 |
| ERVK-6 |
|
endogenous retrovirus group K member 6, envelope
|
|
|
0.521 |
0.808 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |
| MIR21 |
|
microRNA 21
|
|
|
0.363 |
0.846 |
| MIR744 |
|
microRNA 744
|
|
|
0.617 |
0.615 |
| LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
| P2RX5-TAX1BP3 |
|
P2RX5-TAX1BP3 readthrough (NMD candidate)
|
|
|
0.588 |
0.769 |
| ERVK-20 |
|
endogenous retrovirus group K member 20
|
|
|
0.533 |
0.692 |
| MTCO2P12 |
|
MT-CO2 pseudogene 12
|
|
|
0.368 |
0.962 |
| ERVK-32 |
|
endogenous retrovirus group K member 32, envelope
|
|
|
0.522 |
0.692 |
| H3P19 |
|
H3 histone pseudogene 19
|
|
|
0.631 |
0.577 |
| MYOM2 |
P54296
|
myomesin 2
|
|
7.0E-85 |
0.570 |
0.692 |
| IFIH1 |
Q9BYX4
|
interferon induced with helicase C domain 1
|
|
7.0E-44 |
0.471 |
0.808 |
| OAS3 |
Q9Y6K5
|
2'-5'-oligoadenylate synthetase 3
|
Enzyme
|
2.0E-33 |
0.608 |
0.615 |
| DDX58 |
O95786
|
DExD/H-box helicase 58
|
|
1.8E-23 |
0.526 |
0.808 |
| OAS2 |
P29728
|
2'-5'-oligoadenylate synthetase 2
|
Enzyme
|
2.6E-21 |
0.670 |
0.538 |
| GPT |
P24298
|
glutamic--pyruvic transaminase
|
Enzyme
|
3.6E-19 |
0.403 |
0.923 |
| EGFLAM |
Q63HQ2
|
EGF like, fibronectin type III and laminin G domains
|
Enzyme modulator
|
3.8E-19 |
0.743 |
0.462 |